185 related articles for article (PubMed ID: 18801959)
1. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
Steffen BT; Lees SJ; Booth FW
J Appl Physiol (1985); 2008 Dec; 105(6):1950-8. PubMed ID: 18801959
[TBL] [Abstract][Full Text] [Related]
2. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
3. Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue.
Figueras M; Busquets S; Carbó N; Almendro V; Argilés JM; López-Soriano FJ
Int J Oncol; 2005 Sep; 27(3):855-60. PubMed ID: 16077938
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ
Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755
[TBL] [Abstract][Full Text] [Related]
5. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha.
Lin SY; Chen WY; Lee FY; Huang CJ; Sheu WH
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E493-501. PubMed ID: 15522995
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
Liu Z; Miers WR; Wei L; Barrett EJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
[TBL] [Abstract][Full Text] [Related]
8. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
9. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats.
Combaret L; Tilignac T; Claustre A; Voisin L; Taillandier D; Obled C; Tanaka K; Attaix D
Biochem J; 2002 Jan; 361(Pt 2):185-92. PubMed ID: 11772390
[TBL] [Abstract][Full Text] [Related]
10. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice.
Hitt A; Graves E; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):56-66. PubMed ID: 15625704
[TBL] [Abstract][Full Text] [Related]
12. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
[TBL] [Abstract][Full Text] [Related]
13. Autophagic degradation contributes to muscle wasting in cancer cachexia.
Penna F; Costamagna D; Pin F; Camperi A; Fanzani A; Chiarpotto EM; Cavallini G; Bonelli G; Baccino FM; Costelli P
Am J Pathol; 2013 Apr; 182(4):1367-78. PubMed ID: 23395093
[TBL] [Abstract][Full Text] [Related]
14. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
Stovroff MC; Fraker DL; Swedenborg JA; Norton JA
Cancer Res; 1988 Aug; 48(16):4567-72. PubMed ID: 3165053
[TBL] [Abstract][Full Text] [Related]
15. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of genes regulating skeletal muscle mass in the portacaval anastomosis rat.
Dasarathy S; Muc S; Hisamuddin K; Edmison JM; Dodig M; McCullough AJ; Kalhan SC
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1105-13. PubMed ID: 17185634
[TBL] [Abstract][Full Text] [Related]
17. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
Graves E; Hitt A; Pariza MW; Cook ME; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):48-55. PubMed ID: 15625711
[TBL] [Abstract][Full Text] [Related]
18. Time course of ubiquitin-proteasome and macroautophagy-lysosome pathways in skeletal muscle in rats with heart failure.
Fujita N; Fujino H; Sakamoto H; Takegaki J; Deie M
Biomed Res; 2015; 36(6):383-92. PubMed ID: 26700592
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
Tracey KJ; Morgello S; Koplin B; Fahey TJ; Fox J; Aledo A; Manogue KR; Cerami A
J Clin Invest; 1990 Dec; 86(6):2014-24. PubMed ID: 2254457
[TBL] [Abstract][Full Text] [Related]
20. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
